Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MLNT

Melinta Therapeutics

$6.50

0.3 (4.84%)

08:10
05/31/18
05/31
08:10
05/31/18
08:10
Hot Stocks
Melinta Therapeutics making 20 presentations at ASM Microbe meeting »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

MLNT

Melinta Therapeutics

$5.25

(0.00%)

09:29
05/25/18
05/25
09:29
05/25/18
09:29
Upgrade
Melinta Therapeutics rating change at WBB Securities »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 24

    May

MLNT

Melinta Therapeutics

$6.25

-0.2 (-3.10%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Syndicate
Melinta Therapeutics 22M share Secondary priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

MLNT

Melinta Therapeutics

$7.30

-0.2 (-2.67%)

16:12
05/21/18
05/21
16:12
05/21/18
16:12
Syndicate
Melinta Therapeutics files to sell $75M in common stock »

JPMorgan and Jefferies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
MLNT

Melinta Therapeutics

$7.50

0.05 (0.67%)

07:59
05/09/18
05/09
07:59
05/09/18
07:59
Upgrade
Melinta Therapeutics rating change at Baird »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$7.50

0.05 (0.67%)

06:27
05/09/18
05/09
06:27
05/09/18
06:27
Upgrade
Melinta Therapeutics rating change at Baird »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$7.15

0.275 (4.00%)

07:03
05/07/18
05/07
07:03
05/07/18
07:03
Hot Stocks
Melinta Therapeutics enters into partnership with CARB-X »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

MLNT

Melinta Therapeutics

$7.50

0.025 (0.33%)

08:07
04/23/18
04/23
08:07
04/23/18
08:07
Hot Stocks
Melinta Therapeutics presents Phase 3 TANGO II trial at ECCMID »

Melinta Therapeutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MLNT

Melinta Therapeutics

$13.45

(0.00%)

07:08
03/13/18
03/13
07:08
03/13/18
07:08
Earnings
Melinta Therapeutics reports Q4 EPS ($1.48), consensus (76c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

MLNT

Melinta Therapeutics

$13.50

(0.00%)

07:03
03/08/18
03/08
07:03
03/08/18
07:03
Hot Stocks
Melinta Therapeutics partner Menarini Group submits MAA for delafloxacin »

Melinta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.